Seaport Global Initiates Coverage On Ovintiv with Buy Rating, Announces Price Target of $42
Seaport Global analyst Nick Pope initiates coverage on Ovintiv (NYSE:OVV) with a Buy rating and announces Price Target of $42.
ATAI Life Sciences Shares See Volume; Traders Circulate TipRanks Report Titled ‘Billionaire Israel Englander Pours Money Into 3 “Strong Buy” Stocks’ Mentioning Stock
https://www.tipranks.com/news/article/billionaire-israel-englander-pours-money-into-3-strong-buy-stocks/
What 11 Analyst Ratings Have To Say About Ovintiv
Ovintiv (NYSE:OVV) has observed the following analyst ratings within the last quarter:
Morgan Stanley Maintains Overweight on Ovintiv, Lowers Price Target to $46
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Overweight and lowers the price target from $47 to $46.
Cowen & Co. Upgrades Ovintiv to Outperform, Lowers Price Target to $39
Cowen & Co. analyst Gabe Daoud upgrades Ovintiv (NYSE:OVV) from Market Perform to Outperform and lowers the price target from $40 to $39.
Expert Ratings For Ovintiv
Within the last quarter, Ovintiv (NYSE:OVV) has observed the following analyst ratings:
Last 30 Days
1 Month Ago
2 Months Ago
Wells Fargo Maintains Overweight on Ovintiv, Raises Price Target to $40
Wells Fargo analyst Nitin Kumar maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $38 to $40.
Morgan Stanley Maintains Overweight on Ovintiv, Raises Price Target to $47
Morgan Stanley maintains Ovintiv (NYSE:OVV) with a Overweight and raises the price target from $43 to $47.